Gifford Fong Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $722K | Hold |
5,750
| – | – | 0.17% | 96 |
|
2025
Q1 | $787K | Hold |
5,750
| – | – | 0.2% | 93 |
|
2024
Q4 | $879K | Hold |
5,750
| – | – | 0.22% | 91 |
|
2024
Q3 | $1.12M | Hold |
5,750
| – | – | 0.28% | 88 |
|
2024
Q2 | $1.33M | Hold |
5,750
| – | – | 0.35% | 78 |
|
2024
Q1 | $1.24M | Sell |
5,750
-5,750
| -50% | -$1.24M | 0.34% | 80 |
|
2023
Q4 | $2.98M | Hold |
11,500
| – | – | 0.63% | 44 |
|
2023
Q3 | $2.96M | Hold |
11,500
| – | – | 0.71% | 42 |
|
2023
Q2 | $3.28M | Hold |
11,500
| – | – | 0.77% | 40 |
|
2023
Q1 | $3.2M | Hold |
11,500
| – | – | 0.84% | 40 |
|
2022
Q4 | $3.19M | Hold |
11,500
| – | – | 0.73% | 38 |
|
2022
Q3 | $3.07M | Hold |
11,500
| – | – | 0.76% | 35 |
|
2022
Q2 | $2.35M | Hold |
11,500
| – | – | 0.55% | 46 |
|
2022
Q1 | $2.42M | Hold |
11,500
| – | – | 0.44% | 55 |
|
2021
Q4 | $2.76M | Hold |
11,500
| – | – | 0.48% | 50 |
|
2021
Q3 | $3.25M | Hold |
11,500
| – | – | 0.63% | 42 |
|
2021
Q2 | $3.98M | Hold |
11,500
| – | – | 0.77% | 39 |
|
2021
Q1 | $3.22M | Hold |
11,500
| – | – | 0.69% | 41 |
|
2020
Q4 | $2.82M | Hold |
11,500
| – | – | 0.65% | 40 |
|
2020
Q3 | $3.26M | Hold |
11,500
| – | – | 0.87% | 29 |
|
2020
Q2 | $3.08M | Hold |
11,500
| – | – | 0.93% | 29 |
|
2020
Q1 | $3.64M | Buy |
11,500
+10,000
| +667% | +$3.16M | 1.33% | 22 |
|
2019
Q4 | $445K | Hold |
1,500
| – | – | 0.13% | 103 |
|
2019
Q3 | $349K | Hold |
1,500
| – | – | 0.11% | 106 |
|
2019
Q2 | $351K | Hold |
1,500
| – | – | 0.12% | 104 |
|
2019
Q1 | $355K | Hold |
1,500
| – | – | 0.12% | 103 |
|
2018
Q4 | $451K | Hold |
1,500
| – | – | 0.17% | 90 |
|
2018
Q3 | $530K | Hold |
1,500
| – | – | 0.17% | 92 |
|
2018
Q2 | $435K | Buy |
+1,500
| New | +$435K | 0.15% | 91 |
|